TORONTO, July 24, 2024 /CNW/ - MyChoice, a Toronto-based Insurtech company, has released an insurance assistant that allows users in the US and Canada to receive real-time life insurance quotes while ...
Myriad Genetics, Inc. MYGN recently submitted a supplementary premarket approval (sPMA) application to the FDA for its myChoice CDx test. This will enable the identification of women suffering from ...
The filing comes as recent upgrades to NCCN guidelines expand the role of testing in the treatment of ovarian cancer. Myriad Genetics this week submitted the first part of its application to the FDA ...
Leading player in the molecular diagnostics and personalized medicine space, Myriad Genetics Inc.MYGN, announced that its myChoice homologous recombination deficiencies (HRD) test will effectively ...
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that the U.S. Food and Drug Administration ...
The University of Chicago’s myCHOICE (Chicago Options in Career Empowerment) program, which launched in 2014 to broaden experiences in scientific training and career exploration for PhD students, has ...
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- TIAA today announced the launch of TIAA MyChoice MYGA, a multi-year guaranteed annuity (MYGA), offering greater choice as well as secure, competitive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results